Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2010 / Cilt: 19 - Sayı: 3

Recurrent glomerulonephritis after renal transplantation

Böbrek nakli sonrası tekrarlayan glomerülonefritler

Pages
151–156
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this mini review we tried to discuss commonly encountered recurrent glomerulonephritides after renal transplantation

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The most frequent cause of recurrent disease after renal transplantation is recurrent glomerulonephritis.
📊
Key Findings & Data:Among the recurrent glomerulonephritides, type II membranoproliferative glomerulonephritis, immunoglobulin A nephropathy, and focal and segmental glomerulosclerosis have the highest rates of recurrence.
💡
Conclusion & Impact:In this mini review we tried to discuss commonly encountered recurrent glomerulonephritides after renal transplantation
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The most frequent cause of recurrent disease after renal transplantation is recurrent glomerulonephritis. The risk factors for recurrence of glomerulonephritis are largely unknown or imprecise and prediction remains difficult. Among the recurrent glomerulonephritides, type II membranoproliferative glomerulonephritis, immunoglobulin A nephropathy, and focal and segmental glomerulosclerosis have the highest rates of recurrence. Recurrent disease usually presents with similar manifestations as the native disease. With regard to treatment of recurrent glomerular disease in the renal allograft, plasma exchange may be effective in reducing proteinuria in patients with early recurrence of focal and segmental glomerulosclerosis, but immunosuppressive therapy is generally ineffective in the prevention or treatment of recurrent disease. General supportive measures including strict blood pressure control and inhibition or blockade of the renin-angiotensin pathway are helpful in retarding the rate of deterioration in renal allograft function. Despite the risk of recurrence, kidney transplantation following primary glomerulonephritides enjoys graft and patient survival rates comparable to other causes of end-stage renal failure. With a few exceptions, living related renal transplantation is not contraindicated in view of the favorable outcome and the donor shortage. In this mini review we tried to discuss commonly encountered recurrent glomerulonephritides after renal transplantation

Özet

Böbrek nakli sonrası en sık tekrarlayan hastalık grubu glomerülonefritlerdir. Bununla birlikte nakil sonrasında primer glomerüler hastalıkların nüks etmesine ilişkin risk faktörleri tam olarak aydınlatılamamıştır. Tip 2 membranoproliferatif glomerülonefrit, IgA nefropatisi, fokal segmental glomerülonefrit, böbrek nakli sonrasında en sık tekrarlayan glomerülonefritler olarak sıralanabilir. Nakil sonrası tekrarlayan glomerülonefritler, klinik olarak genellikle orijinal hastalılıklara benzer bulgular gösterir. Tekrarlayan glomerülonefritlerin tedavisinde immünosupresif tedavi rejimleri genellikle pek etkili olmamaktadır. Bazı tekrarlayan fokal segmental glomerülonefritlerde, erken dönemde plazma değişiminin proteinuriyi azalttığı gösterilmiştir. Kan basıncının sıkı kontrolü, renin anjiotensinojen aldosteron sisteminin baskılanması gibi genel önlemlerin renal allogreft fonksiyonundaki bozulmayı geciktirdiği bilinmektedir. Genel olarak bakıldığında, nakil sonrası tekrarlayan glomerülonefritlerin greft ve hasta sağkalım oranları çok kötü değildir. Glomerülonefriti olan hastalarda birkaç istisna dışında böbrek naklinin sonuçları yüz güldürücüdür. Biz bu derlememizde nakil sonrası tekrarlayan glomerülonefritler hakkında genel bir bilgi vermeyi amaçladık.

🔖

Cite This Article

YILMAZ, M. İ., AFŞAR, B., ELSÜRER, R. (2022). Recurrent glomerulonephritis after renal transplantation. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 19 - Sayı: 3, 151–156. https://ajindex.com/articles/636493

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ: Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002
  2. 109 2. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000
  3. 612 3. Mathew TH, Mathews DC, Hobbs JB, Kincaid-Smith P: Gbomerular lesions after renal transplantation. Am J Med 1975
  4. 190 4. Morzycka M, Croker BP, Seigler HF, Tisher CC: Evaluation of recurrent gbomerubonephritis in kidney allografts. Am J Med 1982
  5. 598 5. Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz CJ, Roza AM, Vincenti F, George V: Recurrent and de novo glomerular disease after renal transplantation: A report from renal allograft disease registry. Transplantation 1999
  6. 641 6. Briggs JD, Jones E: Recurrence of glomerulonephritis following renal transplantation. Scientific Advisory Board of the ERA-EDTA Registry. Nephrol Dial Transplant 1999
  7. 565 7. Choy BY, Chan TM, Lai KN: Recurrent glomerulonephritis after kidney transplantation. American Journal of Transplantation 2006
  8. 2542 8. Berger J, Noel LH, Nabarra B: Recurrence of mesangial IgA nephropathy after renal transplantation. Contrib Nephrol 1984
  9. 197 9. Odum J, Peh CA, Clarkson AR, Bannister KM, Seymour AE, Gillis D, Thomas AC, Mathew TH, Woodroffe AJ: Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 1994
  10. 312 10. Lim EC, Chia D, Gjertson DW, Koka P, Terasaki PI: In vitro studies to explain high renal allograft survival in IgA nephropathy patients. Transplantation 1993
  11. 999 11. Bachman U, Biava C, Amend W, Feduska N, Melzer J, Salvatierra O: The clinical course of IgA-nephropathy and Henoch-Schonlein purpura following renal transplantation. Transplantation 1986
  12. 515 12. Choy BY, Chan TM, Lo SK, Lo WK, Lai KN: Renal transplantation in patients with primary immunoglobulin A nephropathy. Nephrol Dial Transplant 2003
  13. 2404 13. Moriyama T, Nitta K, Suzuki K, Honda K, Horita S, Uchida K, Yumura W, Tanabe K, Toma H, Nihei H, Yamaguchi Y: Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. Clin Transplant 2005
  14. 48 14. Kesser M, Hiesse C, Hestin D, Mayeux D, Boubenider K, Charpentier B: Recurrence of immunoglobulin A nephropathy afte